Auden Mckenzie (Pharma Division) Ltd is a privately owned, dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK and across Europe.
Auden Mckenzie is committed to providing quality pharmaceutical products and currently holds over 60 product licenses in the UK and across Europe. Our product portfolio consists of a broad range of molecules in various dosage forms, for the treatment of a cross-section of therapeutic areas.
The company specializes in the development and registration of high value, technically demanding formulations and pursues first to file opportunities. With access to both in-house and external regulatory, development and manufacturing capabilities in Europe and Asia, Auden Mckenzie has over 50 pharmaceutical products in development and registration.
The company’s growth is based on strategic selection of products, partners and markets and the utilization of an effective international supply chain. Future growth will be achieved through in-licensing and acquisitions of niche Generics and Branded Pharmaceuticals, internal product developments and collaborative work with strategic partners around the world supporting manufacturing, product development and supply chains.
With a proven ability to achieve profitable sales, the upcoming years will see a stream of new Auden Mckenzie products being launched into the market. By being dedicated, innovative and creative we continue to seek improvement. The company is dedicated to ensuring, a better quality of life for patients and are proud of our association with various Patient Support Groups. Our business confidence is sustained by continued success and company ethos is shaped by our on-going experiences.
To find out more about Auden Mckenzie, please use the following link: